Table 2.
n (%) or Median (interquartile range) | |||||
---|---|---|---|---|---|
Intervention | Control | p value | |||
n = 29 | n = 21 | ||||
Age (years) | 56 | (38 to 65) | 55 | (42 to 63) | 0.94 |
Sex | 0.39 | ||||
Female | 9 | (31) | 9 | (43) | |
Male | 20 | (69) | 12 | (57) | |
Weight (kg) | 71.8 | (67.3 to 82.4) | 74.1 | (68.1 to 77.4) | 0.84 |
Height (cm) | 164.5 | (156.5 to 168.3) | 162.5 | (154.5 to 168.1) | 0.79 |
BMI (kg/m2) | 27.6 | (26.4 to 29.5) | 27.6 | (26.9 to 28.4) | 0.78 |
Abdominal circumference (cm) | 94.0 | (91.8 to 98.0) | 95.0 | (92.0 to 97.5) | 0.93 |
Blood pressure | |||||
Systolic blood pressure (mmHg) | 130 | (120 to 140) | 132 | (120 to 138) | 0.85 |
Diastolic blood pressure (mmHg) | 82 | (72 to 86) | 78 | (71 to 86) | 0.88 |
Serum lipid profile | |||||
Low-density lipoprotein (mg/dl) | 128 | (101 to 147) | 126 | (103 to 148) | 0.86 |
High-density lipoprotein (mg/dl) | 56 | (45 to 61) | 53 | (45 to 62) | 0.85 |
Triglyceride (mg/dl) | 117 | (88 to 171) | 109 | (88 to 126) | 0.52 |
Fasting blood sugar (mg/dl) | 100 | (95 to 109) | 102 | (95 to 117) | 0.42 |
Hemoglobin A1c (%) | 5.5 | (5.2 to 5.9) | 5.7 | (5.3 to 6.2) | 0.15 |
Regular medication | |||||
Antihypertensive drug | 24 | (82) | 15 | (71) | 0.49 |
Lipid-lowering drug | 9 | (31) | 7 | (33) | 0.86 |
Anti-diabetic drug | 0 | (0) | 5 | (24) | 0.01 |
Medical history | |||||
Hypertension | 25 | (86) | 17 | (81) | 0.71 |
Dyslipidemia | 11 | (38) | 8 | (38) | 0.99 |
Type 2 diabetes mellitus | 2 | (7) | 6 | (29) | 0.06 |
Metabolic syndrome criteria | |||||
Japanese criteria | 15 | (52) | 6 | (29) | 0.10 |
NCEP-ATP III criteria | 15 | (52) | 7 | (33) | 0.20 |
Educational background | 0.48 | ||||
Under high school | 7 | (24) | 7 | (33) | |
High school and above | 22 | (76) | 14 | (67) | |
Smoking | 0.87 | ||||
Non-smoker | 24 | (83) | 17 | (81) | |
Currently smoker | 5 | (17) | 4 | (19) | |
Alcohol drinking | 0.53 | ||||
Under once a week | 14 | (48) | 12 | (57) | |
Once a week or more | 15 | (52) | 9 | (43) | |
Weight self monitoring frequencya | 0.73 | ||||
Under once a week | 14 | (48) | 11 | (52) | |
Once a week or more | 14 | (48) | 9 | (43) | |
Home blood pressure monitoring | 0.19 | ||||
Regularly | 24 | (83) | 14 | (67) | |
Not regularly | 5 | (17) | 6 | (33) |
We compared groups with the Mann–Whitney U test or Chi-squared test
BMI, body mass index; NCEP-ATP, Cholesterol Education Program-Adult Treatment Panel
aData were missing for one patient in the intervention group and one patient in the control group